New study aims to unlock secrets of kidney transplant rejection
NCT ID NCT06438107
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This observational study at the University of Pittsburgh will enroll 24 kidney transplant recipients to deeply analyze why some rejections are stubborn. Researchers will use biopsies and blood samples to map immune cells and genetic changes. The goal is to better predict and understand rejection patterns, not to test a new treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors predict and manage kidney transplant rejection more effectively.
- What could go wrong
- This is a small, early observational study with only 24 participants. It aims to gather knowledge, not test a treatment, so direct patient benefits are uncertain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL ALLOGRAFT REJECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UPMC
Pittsburgh, Pennsylvania, 15213, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Kidney transplant trial tests which drug better prevents rejection
- Tiny virus may hold key to better kidney transplant care
- Stem cell trick may free kidney patients from daily pills
- Pee power: urine test may spare kids painful kidney biopsies
- Kidney transplant study: which drug better prevents rejection?
- Can a simple drug make donated kidneys start working faster?